Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Unrealized Losses on Investments (Before Tax)

Unrealized Losses on Investments (Before Tax) at other companies

Amgen logo
AmgenAMGN
$0
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$335K+11,067%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.96B+1,198%
Enterprise value$5.91B+1,379%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate debt securities100,1363(163)99,976
Total marketable securities, current339,47871(240)339,309
Marketable securities, long-term
U.S. treasury securities75,5302(200)75,332
Corporate debt securities18,994(67)18,927
U.S. government agency securities12,905(41)12,864
Total marketable securities, long-term107,4292(308)107,123
Total cash equivalents and marketable securities$492,326$73$(553)$491,846

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax)?
Oruka Therapeutics, Inc. (ORKA) reported unrealized losses on investments (before tax) of $553K in Q1 2026.
How has Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax) increased by 1102.2% year-over-year, from $46K to $553K.
What does unrealized losses on investments (before tax) mean?
This represents the cumulative decrease in the fair market value of investment securities held by the company, measured before accounting for tax effects. It highlights potential volatility in the company's investment portfolio and the impact of market fluctuations on equity.

Ask your AI about Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude